… of looking for a valid muscle wasting biomarker. Myostatin, a muscle mass negative regulator,
… the potential of myostatin as a biomarker of muscle wasting. Based on the literature review, …

… activin A, also trigger muscle protein loss in various catabolic states via the activation of …
Despite these complex pathological findings, accelerated protein degradation by activation …

… Muscle wasting and weakness are common in many disease states and conditions
including aging, cancer cachexia, sepsis, denervation, disuse, inactivity, burns, HIV-acquired …

… Interestingly, some chemotherapeutic drugs state weight loss as side effects, eg, the mTOR
… It has been proposed that serological peptide biomarkers whose tissue and pathology …

… whether muscle wasting manifests in a diabetic state. … with muscle wasting that is evident
prior to the onset of liver disease. In a study of 250 alcoholics, 46% exhibited muscle pathology …

… Muscle wasting is observed in a variety of pathologies such as cancer, chronic kidney disease,
… used to treat aspects of proteostasis and the current state of knowledge are summarized. …

… Both in genetically modified conditions and in physiological or pathological models, it has
never been possible to observe an increase in calpain 3 activity in relation to muscle wasting. …

… there are two pathologies of muscle wasting which are of … Oxidative stress is a state wherein
the normally well-balanced … muscle cells into a catabolic state leading to muscle wasting [40–…

… Muscle wasting also leads to an increased proportion of … , indicative of muscle fibers in a
transitional state, increase after … a mild pathological phenotype in most skeletal muscles, except …

… , or had a primary neuromuscular pathology or … state and severity preclude the dissection
of the effect of paralysis per se or its cumulative effect with corticosteroids on muscle wasting…